Additional Information
Market: ASX
Sector: Pharmaceuticals & Biotechnology
EPIC: STI
Latest Price: A$0.00  (0,00%)
52-week High: A$0.00
52-week Low: A$0.00
Market Cap: A$4.45M
1 year chart
1 day chart
Watchlist/Portfolio

Add to watchlist:

Only registered members can add into watchlist !

Register here !
Stirling Products
www.stirlingproducts.net

Stirling Products (ASX:STI) is a manufacturer and marketer of proprietary and/or patented pharmaceutical products and natural health products for its own interests as well as on a contractual basis for third parties.  Strategically, Stirling Products is positioned to capitalise on the rapidly changing conditions within the global pharmaceutical and health markets.

The Stirling Products corporate headquarters are in Sydney, Australia and its North American pharmaceutical manufacturing operations are based on Cape Breton, Nova Scotia, Canada.

Stirling operates through three main business units each managed by proven industry specialist managers:

- Pharmaceutical & Healthcare
- Research & Development
- Animal Products

Pdf

Stirling Product's TeleMedCare, inks agreement with UK Government's central procurement agency

18th Aug 2010, 9:52 am

Healthcare group, Stirling Products (ASX:STI) has advised that its new UK trading subsidiary TeleMedCare Limited has inked a significant agreement with Buying Solutions, the UK government’s leading centralised procurement agency.

The four year framework agreement grants TeleMedCare approval to bypass the traditional tender and lengthy procurement process that is generally associated with product sales to government departments, NHS Trusts and other public bodies.

Stirling Products managing director, Peter Boonen said it was a great endorsement of the TeleMedCare range of products and services to be approved by the UK Department of Commerce lead procurement agency as a Framework Agreement partner.

The award follows the prior establishment of product capability and performance.

He said, "It is also heartening to see the UK government recognising the efficiencies and savings that e-health solutions can provide to the community and further, being one of the world’s first major active implementers of proven e-health solutions."

"Ultimately, these early initiatives and the removal of the red tape process for procurement of proven product will see the direct benefit flow through to, not only the chronically ill and aged, but also directly to the taxpayer in due course.”

No investment advice

The Company is a publisher and is not registered with or authorised by the Financial Services Authority (FSA). You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.